Research Samples Sample Clauses
Research Samples. Celator shall provide the following Research Samples to BCCA, the receipt of which shall be acknowledged in writing, in connection with the performance of the Work under the Agreement:
Research Samples. At the request of IMSCP, during the Research Period, Cue will use Commercially Reasonable Efforts to transfer to IMSCP the quantity of CUE-102 Molecule specified in the Transfer Plan (“Transferred Product”).
Research Samples. GMP|Genetics shall notify Myriad in writing of the date (the "INITIAL ACCEPTANCE DATE") on which the laboratory at which the Conversion shall be performed (the "GMP|GENETICS Laboratory") will be ready to accept samples. The notice referred to in the immediately preceding sentence shall be given not later than fifteen (15) days prior to the Initial Acceptance Date. GMP|Genetics shall initially send to Myriad, thirty (30) specimens for full sequence analysis ("INITIAL EVALUATION"). Each specimen shall consist of a triplet: an unconverted specimen, a converted (paternal) and a converted (maternal) specimen. Myriad will perform subsequent sequencing on each of these triplet specimens. Myriad will provide GMP with copies of all test results and reports.
Research Samples. (a) In the event that Celator provides to BCCA any Research Samples for the performance of the Work:
(i) Celator covenants and agrees with BCCA that it shall, upon BCCA’s request:
(A) supply BCCA with documentation that describes the Research Samples and sets out any known toxicological effects, and
(B) answer any questions BCCA or its investigators may have regarding the Research Samples prior to or during the performance of the Work; and
(ii) BCCA covenants and agrees with Celator that it shall:
(A) use all Research Samples only in compliance with all applicable laws, regulations and guidelines;
(B) use each Research Sample solely in the performance of the Work and for no other purpose whatsoever;
(C) not administer the Research Samples to humans and in so far as they are administered to animals, no animal to which the Research Samples are administered, or animal product derived therefrom, will be used for food, therapeutic or diagnostic purposes, or kept as a domestic pet or livestock;
(D) modify, reproduce or replicate the Research Samples except as may be required for the performance of the Work;
(E) not distribute or release any Research Sample or any derivative thereof to any person other than BCCA Personnel who require access to the Research Samples in the performance of the Work;
(F) ensure that no BCCA Personnel shall take or send any Research Sample or any part thereof to any location, other than the BCCA facilities at which the Work is to be performed; and
(G) ensure that all BCCA Personnel having access to the Research Samples are made aware of and comply with the terms of this Agreement, including the obligations of confidentiality contained herein.
(b) BCCA acknowledges and agrees that the Research Samples are the property of Celator and that Celator shall retain all right, title and interest in and to the Research Samples, including all proprietary rights thereto, and nothing in this Agreement shall pass or create any right, title or interest in or to the Research Samples to or for the benefit of BCCA. BCCA shall not contest, directly or indirectly, Celator’s ownership of any Research Samples.
(c) BCCA shall return any or all Research Samples in its possession or control:
(i) immediately upon expiration or earlier termination of this Agreement or the applicable R&D Work Schedule, or
(ii) at any time during the Term, upon 30 days prior written notice from Celator, provided that if such Research Samples are necessary for the performance of so...
Research Samples